Table of Content

1. Market Introduction and Scope
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. Executive Insights and Key Takeaways
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Technology
2.4. Snippet by Application
2.5. Snippet by Region
3. Dynamics
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Increasing Adoption of Artificial Intelligence for Faster Drug Development
3.1.1.2. Rise in Technological Advancements
3.1.1.3. XX
3.1.2. Restraints
3.1.2.1. Regulatory Challenges
3.1.2.2. High Cost associated with AI integration
3.1.2.3. XX
3.1.3. Opportunities
3.1.3.1. Expansion in Emerging Markets
3.1.4. Impact Analysis
4. Strategic Insights and Industry Outlook
4.1. Regulatory Analysis
4.2. Market Leaders and Pioneers
4.2.1. Emerging Pioneers and Prominent Players
4.2.2. Established leaders with the largest-selling Brand
4.2.3. Market leaders with established Product
4.3. CXO Perspectives
4.4. Latest Developments and Breakthroughs
4.5. Regulatory and Reimbursement Landscape
4.5.1. North America
4.5.2. Europe
4.5.3. Asia Pacific
4.5.4. South America
4.5.5. Middle East & Africa
4.6. Porter’s Five Forces Analysis
4.7. Supply Chain Analysis
4.8. Patent Analysis
4.9. SWOT Analysis
4.10. Unmet Needs and Gaps
4.11. Recommended Strategies for Market Entry and Expansion
4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
4.13. Pricing Analysis and Price Dynamics
4.14. Key Opinion Leaders
5. AI in Drug Discovery and Development Market, By Technology
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
5.1.2. Market Attractiveness Index, By Technology
5.2. Machine Learning*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Natural Language Processing
5.4. Generative AI
5.5. Others
6. AI in Drug Discovery and Development Market, By Application
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
6.1.2. Market Attractiveness Index, By Application
6.2. Target Discovery & Validation*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Hit Discovery & Virtual Screening
6.4. Hit-to-Lead
6.5. Lead Optimization
6.6. Pre-Clinical Testing
6.7. Clinical Trials
6.8. Others
7. AI in Drug Discovery and Development Market, By Region
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
7.1.2. Market Attractiveness Index, By Region
7.2. North America
7.2.1. Introduction
7.2.2. Key Region-Specific Dynamics
7.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
7.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
7.2.5.1. U.S.
7.2.5.2. Canada
7.2.5.3. Mexico
7.3. Europe
7.3.1. Introduction
7.3.2. Key Region-Specific Dynamics
7.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
7.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
7.3.5.1. Germany
7.3.5.2. U.K.
7.3.5.3. France
7.3.5.4. Spain
7.3.5.5. Italy
7.3.5.6. Rest of Europe
7.4. South America
7.4.1. Introduction
7.4.2. Key Region-Specific Dynamics
7.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
7.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
7.4.5.1. Brazil
7.4.5.2. Argentina
7.4.5.3. Rest of South America
7.5. Asia-Pacific
7.5.1. Introduction
7.5.2. Key Region-Specific Dynamics
7.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
7.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
7.5.5.1. China
7.5.5.2. India
7.5.5.3. Japan
7.5.5.4. South Korea
7.5.5.5. Rest of Asia-Pacific
7.6. Middle East and Africa
7.6.1. Introduction
7.6.2. Key Region-Specific Dynamics
7.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
7.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8. Competitive Landscape and Market Positioning
8.1. Competitive Overview and Key Market Players
8.2. Market Share Analysis and Positioning Matrix
8.3. Strategic Partnerships, Mergers & Acquisitions
8.4. Key Developments in Product Portfolios and Innovations
8.5. Company Benchmarking
9. Company Profiles
9.1. Alphabet (Google DeepMind) *
9.1.1. Company Overview
9.1.2. Product Portfolio
9.1.2.1. Product Description
9.1.2.2. Product Key Performance Indicators (KPIs)
9.1.2.3. Historic and Forecasted Product Sales
9.1.2.4. Product Sales Volume
9.1.3. Financial Overview
9.1.3.1. Company Revenue
9.1.3.2. Geographical Revenue Shares
9.1.3.3. Revenue Forecasts
9.1.4. Key Developments
9.1.4.1. Mergers & Acquisitions
9.1.4.2. Key Product Development Activities
9.1.4.3. Regulatory Approvals, etc.
9.1.5. SWOT Analysis
9.2. Atomwise Inc.
9.3. BenevolentAI
9.4. BioMap
9.5. BioSymetrics
9.6. DEEP GENOMICS.
9.7. Euretos.
9.8. Exscientia
9.9. IBM
9.10. Iktos.
LIST NOT EXHAUSTIVE
10. Appendix
10.1. About Us and Services
10.2. Contact Us